{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:08:26Z","timestamp":1778954906364,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,16]]},"DOI":"10.7759\/cureus.108981","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:00:33Z","timestamp":1778954433000},"source":"Crossref","is-referenced-by-count":0,"title":["Losartan-Induced Sprue-Like Enteropathy Presenting With Isolated Ileal Villous Atrophy: A Report of a Rare and Atypical Case"],"prefix":"10.7759","author":[{"given":"Carlos","family":"Berrocal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanita","family":"Vasquez Villada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Galindo Orrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Libreros Mejia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Marcela","family":"Delgadillo Arco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro Mitsuaki","family":"Suguimoto Erasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Caballero Lagares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Enrique","family":"Solano \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor Alonso","family":"Carrascal L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002208","article-title":"An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy","volume":"33","author":"Mauloni PA","year":"2021","unstructured":"Mauloni PA, Capuani F, Paone C, et al.. An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy. Eur J Gastroenterol Hepatol. 2021, 33:e1060-6. 10.1097\/MEG.0000000000002208","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2026.0872","article-title":"Chronic, noninfectious diarrhea: a review","volume":"335","author":"Singh P","year":"2026","unstructured":"Singh P, Lee A, Sheth NM, Chey WD. Chronic, noninfectious diarrhea: a review. JAMA. 2026, 335:1250-62. 10.1001\/jama.2026.0872","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S337640","article-title":"Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations","volume":"18","author":"Gallo G","year":"2022","unstructured":"Gallo G, Volpe M, Rubattu S. Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations. Vasc Health Risk Manag. 2022, 18:507-15. 10.2147\/VHRM.S337640","journal-title":"Vasc Health Risk Manag"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53556","article-title":"Olmesartan-induced enteropathy: when the treatment of one disease causes another","volume":"16","author":"Santos S","year":"2024","unstructured":"Santos S, Costa RS, Ferreira S, Gomes Ferreira S, Maciel R. Olmesartan-induced enteropathy: when the treatment of one disease causes another. Cureus. 2024, 16:e53556. 10.7759\/cureus.53556","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12937","article-title":"Olmesartan-associated enteropathy: results of a national survey","volume":"40","author":"Marthey L","year":"2014","unstructured":"Marthey L, Cadiot G, Seksik P, et al.. Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther. 2014, 40:1103-9. 10.1111\/apt.12937","journal-title":"Aliment Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goz019","article-title":"Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review","volume":"7","author":"Kamal A","year":"2019","unstructured":"Kamal A, Fain C, Park A, Wang P, Gonzalez-Velez E, Leffler DA, Hutfless SM. Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review. Gastroenterol Rep (Oxf). 2019, 7:162-7. 10.1093\/gastro\/goz019","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17855","article-title":"Systematic review: clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers","volume":"59","author":"Schiepatti A","year":"2024","unstructured":"Schiepatti A, Minerba P, Puricelli M, Maimaris S, Arpa G, Biagi F, Sanders DS. Systematic review: clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers. Aliment Pharmacol Ther. 2024, 59:432-44. 10.1111\/apt.17855","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17977","article-title":"Letter: the enigma of angiotensin receptor blocker-associated enteropathy","volume":"59","author":"Mohamedrashed M","year":"2024","unstructured":"Mohamedrashed M, Nedumannil L, Garg M. Letter: the enigma of angiotensin receptor blocker-associated enteropathy. Aliment Pharmacol Ther. 2024, 59:1636-7. 10.1111\/apt.17977","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13413","article-title":"Immunopathogenesis of olmesartan-associated enteropathy","volume":"42","author":"Marietta EV","year":"2015","unstructured":"Marietta EV, Nadeau AM, Cartee AK, et al.. Immunopathogenesis of olmesartan-associated enteropathy. Aliment Pharmacol Ther. 2015, 42:1303-14. 10.1111\/apt.13413","journal-title":"Aliment Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309690","article-title":"Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study","volume":"65","author":"Basson M","year":"2016","unstructured":"Basson M, Mezzarobba M, Weill A, Ricordeau P, Allemand H, Alla F, Carbonnel F. Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study. Gut. 2016, 65:1664-9. 10.1136\/gutjnl-2015-309690","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.08.061","article-title":"AGA clinical practice update on the evaluation and management of seronegative enteropathies: expert review","volume":"160","author":"Leonard MM","year":"2021","unstructured":"Leonard MM, Lebwohl B, Rubio-Tapia A, Biagi F. AGA clinical practice update on the evaluation and management of seronegative enteropathies: expert review. Gastroenterology. 2021, 160:437-44. 10.1053\/j.gastro.2020.08.061","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12780","article-title":"Systematic review: sprue-like enteropathy associated with olmesartan","volume":"40","author":"Ianiro G","year":"2014","unstructured":"Ianiro G, Bibb\u00f2 S, Montalto M, Ricci R, Gasbarrini A, Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 2014, 40:16-23. 10.1111\/apt.12780","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13070223","article-title":"Atypical rapid onset of olmesartan-induced enteropathy with recurrence after rechallenge","volume":"13","author":"Bekkai L","year":"2025","unstructured":"Bekkai L, Ibn Majah A, Verset L, et al.. Atypical rapid onset of olmesartan-induced enteropathy with recurrence after rechallenge. Diseases. 2025, 13:223. 10.3390\/diseases13070223","journal-title":"Diseases"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.07.086","article-title":"AGA clinical practice update on management of refractory celiac disease: expert review","volume":"163","author":"Green PH","year":"2022","unstructured":"Green PH, Paski S, Ko CW, Rubio-Tapia A. AGA clinical practice update on management of refractory celiac disease: expert review. Gastroenterology. 2022, 163:1461-9. 10.1053\/j.gastro.2022.07.086","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000383","article-title":"A case of severe sprue-like enteropathy associated with losartan","volume":"49","author":"Negro A","year":"2015","unstructured":"Negro A, Rossi GM, Santi R, Iori V, De Marco L. A case of severe sprue-like enteropathy associated with losartan. J Clin Gastroenterol. 2015, 49:794. 10.1097\/MCG.0000000000000383","journal-title":"J Clin Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.281","article-title":"A pitfall in suspected (refractory) celiac disease: losartan-induced enteropathy","volume":"112","author":"van Gils T","year":"2017","unstructured":"van Gils T, Robijn RJ, Bouma G, Neefjes-Borst EA, Mulder CJ. A pitfall in suspected (refractory) celiac disease: losartan-induced enteropathy. Am J Gastroenterol. 2017, 112:1754-5. 10.1038\/ajg.2017.281","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4645","article-title":"Cutaneous ulcers in association with sprue-like enteropathy secondary to losartan","volume":"9","author":"Essien F","year":"2021","unstructured":"Essien F, Wassem J, Tate J, Roberts J. Cutaneous ulcers in association with sprue-like enteropathy secondary to losartan. Clin Case Rep. 2021, 9:e04645. 10.1002\/ccr3.4645","journal-title":"Clin Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.12.001","article-title":"Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology","volume":"50","author":"Burbure N","year":"2016","unstructured":"Burbure N, Lebwohl B, Arguelles-Grande C, Green PH, Bhagat G, Lagana S. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology. Hum Pathol. 2016, 50:127-34. 10.1016\/j.humpath.2015.12.001","journal-title":"Hum Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2024.45.4.20230739","article-title":"Enteropathy and intestinal malabsorption in patients treated with antihypertensive drugs. A retrospective cohort study","volume":"45","author":"Lee SR","year":"2024","unstructured":"Lee SR, Lee EG, Cho YH, et al.. Enteropathy and intestinal malabsorption in patients treated with antihypertensive drugs. A retrospective cohort study. Saudi Med J. 2024, 45:437-41. 10.15537\/smj.2024.45.4.20230739","journal-title":"Saudi Med J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: from biomarker to biological function","volume":"70","author":"Jukic A","year":"2021","unstructured":"Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE. Calprotectin: from biomarker to biological function. Gut. 2021, 70:1978-88. 10.1136\/gutjnl-2021-324855","journal-title":"Gut"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492739-losartan-induced-sprue-like-enteropathy-presenting-with-isolated-ileal-villous-atrophy-a-report-of-a-rare-and-atypical-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:00:36Z","timestamp":1778954436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492739-losartan-induced-sprue-like-enteropathy-presenting-with-isolated-ileal-villous-atrophy-a-report-of-a-rare-and-atypical-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.108981","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,16]]}}}